PULMONX CORPORATION Payments of Stock Issuance Costs
PULMONX CORPORATION (LUNG) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2022-03-01
- PULMONX CORPORATION payments of stock issuance costs for the quarter ending 2021-12-31 was $0.00.
- PULMONX CORPORATION payments of stock issuance costs for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- PULMONX CORPORATION payments of stock issuance costs for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- PULMONX CORPORATION payments of stock issuance costs for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- PULMONX CORPORATION payments of stock issuance costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- PULMONX CORPORATION payments of stock issuance costs for fiscal 2020 was $2.46M, a 333.45% increase from fiscal 2019.
- PULMONX CORPORATION payments of stock issuance costs for fiscal 2019 was $568.00K.
- PULMONX CORPORATION payments of stock issuance costs for fiscal 2018 was $0.00.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | -$265.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $0.00 10-Q · filed 2021-08-10 | -$265.00K derived: sum of 3 quarters · filed 2022-03-01 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 | -$265.00K derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $2.06M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-12-31 | -$265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $2.06M derived: sum of 3 quarters · filed 2022-03-01 | $2.46M 10-K · filed 2022-03-01 |
| 2020-09-30 | $265.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.33M derived: sum of 2 quarters · filed 2021-11-09 | $2.73M 10-Q · filed 2021-11-09 | $3.27M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $2.46M 10-Q · filed 2021-08-10 | $3.01M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $400.00K 10-Q · filed 2021-05-12 | $947.00K derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $547.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $568.00K 10-K · filed 2021-03-15 | ||
| 2019-09-30 | $21.00K 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |